Cargando…
DNM2 levels normalization improves muscle phenotypes of a novel mouse model for moderate centronuclear myopathy
Dynamin 2 (DNM2) is a ubiquitously expressed GTPase regulating membrane trafficking and cytoskeleton dynamics. Heterozygous dominant mutations in DNM2 cause centronuclear myopathy (CNM), associated with muscle weakness and atrophy and histopathological hallmarks as fiber hypotrophy and organelles mi...
Autores principales: | de Carvalho Neves, Juliana, Moschovaki-Filippidou, Foteini, Böhm, Johann, Laporte, Jocelyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400865/ https://www.ncbi.nlm.nih.gov/pubmed/37547294 http://dx.doi.org/10.1016/j.omtn.2023.07.003 |
Ejemplares similares
-
A dog model for centronuclear myopathy carrying the most common DNM2 mutation
por: Böhm, Johann, et al.
Publicado: (2022) -
Phenotypic Spectrum of DNM2-Related Centronuclear Myopathy
por: Hayes, Leslie Hotchkiss, et al.
Publicado: (2022) -
DNM2 mutations in a cohort of sporadic patients with centronuclear myopathy
por: Abath, Osorio, et al.
Publicado: (2015) -
Centronuclear (myotubular) myopathy
por: Jungbluth, Heinz, et al.
Publicado: (2008) -
A rare case of centronuclear myopathy with DNM2 mutation: genotype–phenotype correlation
por: Aghbolaghi, Amir Ghorbani, et al.
Publicado: (2017)